FDA 483 - Heartware, Inc.

Heartware, Inc., a sponsor of investigational studies, was cited for two observations during an FDA inspection. The firm failed to promptly secure compliance from a clinical investigator regarding trial data and adverse event reporting, even as the site became overwhelmed with open queries. Additionally, a monitor failed to submit monitoring visit reports within the required timeframe for another protocol.